WASHINGTON (MedPage Today) -- The FDA has asked Ariad Pharmaceuticals to suspend marketing and sales of Iclusig (ponatinib), a chemotherapy agent used to treat leukemia, pending further investigation of reports of "life-threatening blood clots and severe narrowing of blood vessels". via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment